MicroTrace BioAI Overview
- Status
-
Private
- Latest Deal Type
-
Seed
- Investors
-
3
MicroTrace BioAI General Information
Description
Developer of fragment-native artificial intelligence models designed to decode molecular signals from cell-free DNA. The company develops multimodal AI models that learn from DNA, RNA, and protein signals on individual fragments, enabling clinical researchers to identify patterns relevant to cancer and improve diagnostic decision-making.
Contact Information
Website
www.microtracebioai.comCorporate Office
- San Jose, CA
- United States
Corporate Office
- San Jose, CA
- United States
MicroTrace BioAI Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 01-Oct-2026 | Completed | Product Development |
MicroTrace BioAI Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Betafund Ai | Accelerator/Incubator | Minority | ||
| Boutique Venture Partners | Venture Capital | Minority | ||
| xNova VC | Venture Capital | Minority |
MicroTrace BioAI FAQs
-
Where is MicroTrace BioAI headquartered?
MicroTrace BioAI is headquartered in San Jose, CA.
-
What industry is MicroTrace BioAI in?
MicroTrace BioAI’s primary industry is Other Healthcare Technology Systems.
-
Is MicroTrace BioAI a private or public company?
MicroTrace BioAI is a Private company.
-
What is MicroTrace BioAI’s current revenue?
The current revenue for MicroTrace BioAI is .
-
Who are MicroTrace BioAI’s investors?
Betafund Ai, Boutique Venture Partners, and xNova VC have invested in MicroTrace BioAI.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process